Paper20175270
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Warren KA and 2 others. Retina, 2010. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. Papers, record 20175270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175270
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
- PubMed
Topics30
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiogenesis Inhibitors | Major topic |
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Antibodies, Monoclonal | Major topic |
| Glucocorticoids | Major topic |
| Macular Edema | Major topic |
| Pseudophakia | Major topic |
| Triamcinolone Acetonide | Major topic |
| Aged | |
| Aged, 80 and over | |
| Antibodies, Monoclonal, Humanized | |
| Benzeneacetamides | |
| Benzophenones | |
| Bevacizumab | |
| Bromobenzenes | |
| Diclofenac | |
| Drug Therapy, Combination | |
| Female | |
| Fluorescein Angiography | |
| Humans | |
| Injections | |
| Ketorolac | |
| Male | |
| Middle Aged | |
| Phenylacetates | |
| Retina | |
| Single-Blind Method | |
| Treatment Outcome | |
| Vascular Endothelial Growth Factor A | |
| Visual Acuity | |
| Vitreous Body |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41948371 | Imaging cystoid macular oedema secondary to branch retinal vein occlusion with spectral domain optical coherence tomography: A case report. | SAGE Open Med Case Rep | 2026 | https://conductscience.org/library/papers/41948371 | PubMed |
| 41557186 | Efficacy of anti-VEGF therapy for Irvine-Gass syndrome: a systematic review and meta-analysis. | Graefes Arch Clin Exp Ophthalmol | 2026 | https://conductscience.org/library/papers/41557186 | PubMed |
| 37723463 | Real-world treatment patterns and economic burden of post-cataract macular edema. | BMC Ophthalmol | 2023 | https://conductscience.org/library/papers/37723463 | PubMed |
| 37083870 | Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema. | Int Ophthalmol | 2023 | https://conductscience.org/library/papers/37083870 | PubMed |
| 36520144 | Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36520144 | PubMed |
| 34708787 | Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema. | Indian J Ophthalmol | 2021 | https://conductscience.org/library/papers/34708787 | PubMed |
| 34640393 | Current Management Options in Irvine-Gass Syndrome: A Systemized Review. | J Clin Med | 2021 | https://conductscience.org/library/papers/34640393 | PubMed |
| 33492546 | Epiretinal membrane vitrectomy: outcomes with or without cataract surgery and a novel prognostic factor for cystoid macular edema. | Graefes Arch Clin Exp Ophthalmol | 2021 | https://conductscience.org/library/papers/33492546 | PubMed |
| 33192068 | Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema. | Ther Clin Risk Manag | 2020 | https://conductscience.org/library/papers/33192068 | PubMed |
| 32671307 | The Effect of Topical Bromfenac on Intraretinal and Subretinal Fluid in Neovascular Age-Related Macular Degeneration. | J Curr Ophthalmol | 2020 | https://conductscience.org/library/papers/32671307 | PubMed |
| 31664337 | Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids. | Arq Bras Oftalmol | 2020 | https://conductscience.org/library/papers/31664337 | PubMed |
| 31571815 | Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges. | Clin Ophthalmol | 2019 | https://conductscience.org/library/papers/31571815 | PubMed |
| 30809482 | Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome. | Int J Ophthalmol | 2019 | https://conductscience.org/library/papers/30809482 | PubMed |
| 30614750 | Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study. | J Ocul Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30614750 | PubMed |
| 30581301 | Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome. | Saudi J Ophthalmol | 2018 | https://conductscience.org/library/papers/30581301 | PubMed |
| 30046541 | Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification. | Int J Ophthalmol | 2018 | https://conductscience.org/library/papers/30046541 | PubMed |
| 28985220 | Combinatorial treatment with topical NSAIDs and anti-VEGF for age-related macular degeneration, a meta-analysis. | PLoS One | 2017 | https://conductscience.org/library/papers/28985220 | PubMed |
| 27822006 | Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review. | Clin Ophthalmol | 2016 | https://conductscience.org/library/papers/27822006 | PubMed |
| 27801522 | Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27801522 | PubMed |
| 27697257 | Cataract surgery and nonsteroidal antiinflammatory drugs. | J Cataract Refract Surg | 2016 | https://conductscience.org/library/papers/27697257 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20175270
GET https://conductscience.org/api/papers/v1/20175270/cited_by?page=2